| Literature DB >> 33921981 |
Anne Brigitte Kruse1, Nadine Schlueter2, Viktoria Konstanze Kortmann1, Cornelia Frese3, Annette Anderson1, Annette Wittmer4, Elmar Hellwig1, Kirstin Vach5, Ali Al-Ahmad1.
Abstract
The aim of this randomized, controlled clinical trial was to isolate and identify viable microorganisms in the saliva of study participants that continuously used a stannous and fluoride ion (F/Sn)-containing toothpaste and mouth rinse over a period of three years in comparison to a control group that used stannous ion free preparations (noF/Sn) over the same time period. Each group (F/Sn and noF/Sn) included 16 participants that used the respective oral hygiene products over a 36-month period. Stimulated saliva samples were collected at baseline (T0) and after 36 months (T1) from all participants for microbiological examination. The microbial composition of the samples was analyzed using culture technique, matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry, and 16S rDNA Polymerase Chain Reaction (PCR). There were only minor differences between both groups when comparing the absolute values of viable microbiota and bacterial composition. The treatment with F/Sn led to a slight decrease in disease-associated and a slight increase in health-associated bacteria. It was shown that the use of stannous ions had no negative effects on physiological oral microbiota even after prolonged use. In fact, a stabilizing effect of the oral hygiene products containing stannous ions on the health-associated oral microbiota could be expected.Entities:
Keywords: culture technique; fluoride; salivary bacteria; stannous ion; viable bacteria
Year: 2021 PMID: 33921981 PMCID: PMC8143473 DOI: 10.3390/antibiotics10050481
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1Anaerobic bacteria in culture. Different bacterial colonies which were anaerobically cultured from total salivary bacteria on an HCB agar plate for 10 days.
Demographic data.
|
Participants ( | Test Group ( | Control Group ( |
|---|---|---|
| Age | 35.8 ± 10.8 | 34.9 ± 8.52 |
| Gender | 12 (75%) male | 15 (94%) male |
The values are given as means with standard deviations.
Figure 2Subgroups of bacterial species detected in saliva. Bacterial counts of subgroups of bacterial species for the test group and the control group at baseline (T0) and after 36 months (T1); values are given as means in log10 CFU/mL; n = 16 for each group.
Figure 3Gram-negative and Gram-positive species detected in saliva. Bacterial counts of Gram-negative and Gram-positive bacterial species for the test group and the control group at baseline (T0) and after 36 months (T1); values are given as means in log10 CFU/mL; n = 16 for each group.
Figure 4Microbial composition of saliva samples in Log10 CFU/mL. Bacterial counts of bacterial species for the test group and the control group at baseline (T0) and after 36 months (T1); values are given as means in log10 CFU/mL; spp. = species pluralis, HACEK = Haemophilus spp., Aggregatibacter actinomycetemcomitans, Aggregatibacter aphrophilus, Cardiobacterium hominis, Eikenella corrodens, Kingella spp.; n = 16 for each group.